09 Oct, 2026
This story has been updated. The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas commonly used by postdoctoral researchers, a core part…
Welcome to the debut of ID Consult, a new STAT column from infectious disease physician Krutika Kuppalli about diseases, outbreak response, global health, and health policy. A 28-year-old laboratory worker…
President Donald Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time, to more than 20 million seniors, giving them $90 each…
Finding information from the National Institutes of Health about human health, disease, and biomedical research is about to look a lot different. On Monday, the NIH will unveil a new…
WASHINGTON — The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to only four companies. The Global Benchmark for…

STAT readers weigh in on massive health care profits

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a […]

25 mins read

I’m stuck in the gray market for GLP-1s

On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy to $150 a month. Even after a top health official suggested price negotiations between drugmakers and the administration were ongoing, the announcement sent Novo Nordisk and Eli Lilly stocks tumbling. For patients who’ve been priced out, that […]

10 mins read

Enhertu shows promise as treatment for early breast cancer at ESMO 2025

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BERLIN — Enhertu has become a staple treatment in advanced breast cancer, but new data presented Saturday at the European Society for Medical Oncology’s annual conference show the drug can have powerful benefits for patients when […]

1 min read